Managing Risks with Immune Therapies in Multiple Sclerosis.
Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Mares J, Hartung HP, Kremer D.
Förster M, et al. Among authors: hohlfeld r.
Drug Saf. 2019 May;42(5):633-647. doi: 10.1007/s40264-018-0782-8.
Drug Saf. 2019.
PMID: 30607830
Review.